Loading...

VTVT VTV THERAPEUTICS INC Product Launches 8-K Filing

VTV

VTVT

VTV THERAPEUTICS INC

(VTVT)

2024 8-K

Investor Update

Financial Results Announced

Investor Presentation Update

License Agreement Update

By-Law Amendment

Financial Results Release

Fireside Chat Announcement

Private Placement Agreement

Investor Meetings

Financial Statements

Investor Presentation

Financial Results

CFO Resignation

Investor Presentation

Financial Results

License Termination

Financial Results Announcement

Product Discontinuation

Agreement Amendment

Annual Meeting Results

Financial Results Announcement

Compliance regained with Na...

Appointment of Director

Financial Results Announcement

Investor Meetings

Sales Agreement with Cowen ...

Private Placement and Board...

Termination of License Agre...

Compliance with Minimum Bid...

Reverse Stock Split

Reverse Stock Split

Investor Conferences

Financial Results Announcement

Financial Results Announcement

Forced Delisting

Delisting Notice

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Regulation FD Disclosure

External Links:

vTv Therapeutics announces that their Cadisegliatin Program for Type 1 Diabetes has been placed on clinical hold.

AI Assistant

VTV THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.